Fundraising Fox

Mereo BioPharma Group

NASDAQ: MREO

London · Incorporated in United Kingdom · 2 known investors

Mereo BioPharma is a biopharmaceutical company that develops novel therapies for rare diseases with limited or no treatment options, focusing on lead programs in osteogenesis imperfecta (OI) and Alpha-1 Antitrypsin Deficiency-associated Lung Disease (AATD-LD). It operates a capital-efficient model, acquiring high-potential therapies from pharmaceutical and biotechnology companies and advancing them through clinical development in partnership with patient communities.

Biotech

Founders & leadership

JRJohn Richard
John RichardHead of Corporate Development and Co-Founder
DD
Dr. Denise Scots-KnightChief Executive Officer and Co-Founder
CS
Charles SermonGeneral Counsel and Co-Founder
RJ
Richard JonesChief Financial Officer
JH
Jill HenrichSenior Vice President

Board

DD
Dr. Deepa PakianathanNon-Executive Director
DP
Dr. Peter FellnerChairman
KK
Kunal KashyapNon-Executive Director
PB
Paul BlackburnNon-Executive Director
PB
Peter BainsNon-Executive Director
MW
Michael WyzgaNon-Executive Director
DA
Dr. Anders EkblomNon-Executive Director

Investors · 2

Pontifax Venture CapitalHerzeliya · $6.3M – $128M
Vivo CapitalPalo Alto · $10M – $50M

Reported raises · per SEC filings

Form D private placements

$70M disclosed across 1 round · 2020

▶$70MraisedJun 2020 · 25 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Dr. Peter FellnerDirector
  • Richard JonesExecutive Officer, Director
  • Kunal KashyapDirector
  • Paul BlackburnDirector
  • John RichardExecutive Officer
  • Dr. Denise Scots-KnightExecutive Officer, Director
  • Jill HenrichExecutive Officer
  • Charles SermonExecutive Officer
  • Peter BainsDirector
  • Michael WyzgaDirector
  • Dr. Anders EkblomDirector
  • Dr. Deepa PakianathanDirector
  • Dr. Alastair MacKinnonExecutive Officer
Offering amount
$70M
Amount sold
$70M
Minimum investment
$1
Sales commissions
$4.2M
Placement agents
SVB Leerink LLC
First sale
Jun 2020
Incorporated
Other, United Kingdom
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Bioworld67 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Mereo BioPharma Group for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Mereo BioPharma Group plc Q2 2026: Revenue $0 Net loss $7.01M, EPS $(0.01) — 10-Q Summarytradingview.com · Aug 2026Defilade Capital Management L.P. Makes New Investment in Mereo BioPharma Group plc - Sponsored ADR $MREOmarketbeat.com · Aug 2026Novartis partners with Phase 4 Partners and institutional investors to help create Mereo BioPharma Group Ltd | Novartisnovartis.com · Jul 2015Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company | Fierce Biotechfiercebiotech.com · Jul 2015Mereo BioPharma Group PLC ADR (MREO)morningstar.com

Frequently asked questions

What does Mereo BioPharma Group do?
Mereo BioPharma is a biopharmaceutical company that develops novel therapies for rare diseases with limited or no treatment options, focusing on lead programs in osteogenesis imperfecta (OI) and Alpha-1 Antitrypsin Deficiency-associated Lung Disease (AATD-LD). It operates a capital-efficient model, acquiring high-potential therapies from pharmaceutical and biotechnology companies and advancing them through clinical development in partnership with patient communities.
Who founded Mereo BioPharma Group?
Mereo BioPharma Group was founded by John Richard, Dr. Denise Scots-Knight, Charles Sermon.
Who are Mereo BioPharma Group's investors?
Mereo BioPharma Group's investors include Pontifax Venture Capital, Vivo Capital.
How much funding has Mereo BioPharma Group raised?
Mereo BioPharma Group has disclosed $70M raised across 1 round.
Where is Mereo BioPharma Group headquartered?
Mereo BioPharma Group is headquartered in London.